Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

The $200 Popcorn Popper That Keeps Selling Out

October 1, 2026

Challenged Athletes Foundation Receives Rings of Gold Award from U.S. Olympic & Paralympic Committee

October 1, 2026

CleanChoice Energy Closes Approximately $166M in Project Financing and Tax Equity for Two Solar Projects

October 1, 2026

Fabletics Launches Fabletics Reserve Credit Card, Expanding Value and Loyalty Perks to Its More than 2.7 Million Members

October 1, 2026

First Merchants Bank CEO Mark Hardwick to retire at the end of 2026 and President Mike Stewart to become President and CEO

October 1, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » QUINT Brings Concentrated Exosome Technology Home With Monthly Skin and Scalp Protocols
Press Release

QUINT Brings Concentrated Exosome Technology Home With Monthly Skin and Scalp Protocols

By News RoomSeptember 9, 20263 Mins Read
QUINT Brings Concentrated Exosome Technology Home With Monthly Skin and Scalp Protocols
Share
Facebook Twitter LinkedIn Pinterest Email

The beauty biotechnology brand combines 25 billion exosomes with precision microneedling in guided, once-monthly systems for face and scalp.

Q.Face

Q.Face

Q.Scalp

Q.Scalp
Q.Scalp

IRVING, TX, Sept. 10, 2026 (GLOBE NEWSWIRE) — As exosome technology gains attention across professional aesthetics and advanced beauty, QUINT is bringing the emerging category into the home through structured microneedling protocols designed for visible skin and scalp results.

Unlike daily serums that add exosomes to an existing skincare routine, QUINT’s Q.FACE and Q.SCALP systems are built around a concentrated monthly application. Each protocol pairs a single-use precision microneedling vial with a topical formula containing 25 billion exosomes, creating a guided approach centered on potency, delivery and consistency.

“Consumers are becoming increasingly interested in exosomes, but there is still significant confusion around concentration, application and what differentiates one formula from another,” said Sagar Nepal, founder and chief scientist of QUINT. “We created QUINT to offer a more intentional approach: a defined dose, a delivery method designed for the formula and a clear monthly protocol.”

A Structured Alternative to Daily Application
QUINT was developed around the idea that advanced skincare should not require complicated routines or frequent professional appointments. Rather than positioning exosomes as another daily cosmetic ingredient, the brand organizes the technology into a guided three-month protocol.

The once-monthly cadence is designed to simplify use while allowing time between applications. Each system includes step-by-step instructions and premeasured, single-use components intended to remove much of the guesswork commonly associated with at-home microneedling.

QUINT’s approach is defined by three elements:

  • Concentration: Each monthly application contains 25 billion exosomes.
  • Delivery: The topical formula is paired with a precision microneedling applicator.
  • Cadence: The protocol is used once per month over three months.

Together, these elements create a standardized framework for incorporating exosome technology into an at-home skin or scalp routine.

Two Exosome Protocols for Skin and Scalp
Q.FACE is a three-month facial protocol designed to support smoother-looking skin, more even-looking tone and visibly refined texture. Each monthly treatment combines precision microneedling with an exosome-rich topical formula developed specifically for facial application.
Q.SCALP applies the same structured model to the scalp. Designed for people concerned with the appearance of thinning, uneven density or changes in scalp condition, the protocol supports a healthier-looking scalp environment and the appearance of fuller-looking hair over time.

Although the protocols address different cosmetic concerns, both follow the same system of concentrated dosing, precision application and once-monthly use.

Bringing Professional Structure Into the Home
Interest in professional-inspired skincare has expanded beyond individual ingredients to include the way products are dosed, delivered and used over time. QUINT reflects that shift by treating at-home care as a defined protocol rather than a collection of standalone products.

The brand maintains a cosmetic, appearance-focused positioning and provides detailed usage guidance intended to encourage consistent, responsible application.
“Advanced technology should not make a routine more confusing,” Nepal added. “Our goal is to translate complex skin science into a system that feels clear, purposeful and realistic to use at home.”

Availability
Q.FACE and Q.SCALP are available exclusively through QUINT’s direct-to-consumer website at quintskin.com.

Case studies, product samples, additional imagery or interviews QUINT founder and chief scientist Sagar Nepal available upon request. 

About QUINT
QUINT is the direct-to-consumer retail arm of Quintessence Biologics. It was created to bridge advanced exosome research and at-home application through structured microneedling protocols for skin and scalp. The brand’s approach centers on precision, potency, and consistency, introducing a new framework for at-home care designed to support visible results over time. 

Contact Info

Arantza Ramos
[email protected]

Attachments

  • Q.Face
  • Q.Scalp

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

The $200 Popcorn Popper That Keeps Selling Out

Challenged Athletes Foundation Receives Rings of Gold Award from U.S. Olympic & Paralympic Committee

CleanChoice Energy Closes Approximately $166M in Project Financing and Tax Equity for Two Solar Projects

Fabletics Launches Fabletics Reserve Credit Card, Expanding Value and Loyalty Perks to Its More than 2.7 Million Members

First Merchants Bank CEO Mark Hardwick to retire at the end of 2026 and President Mike Stewart to become President and CEO

Primech Holdings (Nasdaq: PMEC) Unveils Primech Vision, Integrating a Multi-Robot Facility Fleet and Workforce on One Platform; Live Customer Demonstrations Begin October 2026

Easy Environmental Solutions Ships First Commercial EasyFEN™ System to Kenya

The News Forum Presents Aftershock: The World After October 7, 2023

BloFin returns as TOKEN2049 Singapore title sponsor, opens its “NEXT WHALE ERA” chapter with 3rd anniversary afterparty

Editors Picks

Challenged Athletes Foundation Receives Rings of Gold Award from U.S. Olympic & Paralympic Committee

October 1, 2026

CleanChoice Energy Closes Approximately $166M in Project Financing and Tax Equity for Two Solar Projects

October 1, 2026

Fabletics Launches Fabletics Reserve Credit Card, Expanding Value and Loyalty Perks to Its More than 2.7 Million Members

October 1, 2026

First Merchants Bank CEO Mark Hardwick to retire at the end of 2026 and President Mike Stewart to become President and CEO

October 1, 2026

Latest News

Primech Holdings (Nasdaq: PMEC) Unveils Primech Vision, Integrating a Multi-Robot Facility Fleet and Workforce on One Platform; Live Customer Demonstrations Begin October 2026

October 1, 2026

Police seek answers in crash that killed 2 elders, hurt 2 others on BC First Nation

October 1, 2026

An AI agent tried to hack Canadian government website, researchers say

October 1, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version